Eli Lilly Launches Employer Connect Platform Offering $449 Zepbound KwikPen Coverage
Eli Lilly launched Employer Connect with over 15 independent program administrators and nationwide pharmacy support, offering Zepbound KwikPen at $449 for all doses with reduced employee cost-share pricing. The program aims to close access gaps for half of commercially insured employees lacking obesity coverage while addressing a $1.7 trillion annual burden.
1. Employer Connect Platform Launch
Eli Lilly introduced Employer Connect with over fifteen independent program administrators and nationwide pharmacy support from HealthDyne and CenterWell, enabling employers to design flexible obesity benefit plans.
2. Zepbound KwikPen Pricing and Access
Through the platform, Zepbound KwikPen for single-patient use is available at $449 across all doses, with employers selecting cost-sharing models to lower out-of-pocket expenses for employees.
3. Market Impact and Coverage Gap
Obesity affects more than 100 million U.S. adults and incurs a $1.7 trillion annual economic burden, while roughly half of commercially insured employees currently lack coverage for obesity medications.